Kim Lee
Investor Relations Kontakt bei RIOCAN REAL ESTATE INVESTMENT TRUST
Vermögen: 86 709 $ am 30.04.2024
Profil
Kim Lee is currently the Vice President of Investor Relations at RioCan Real Estate Investment Trust.
Previously, she held the same position at Maple Leaf Foods, Inc. from 2018 to 2020, and was the VP of Investor Relations and Business Intelligence at Choice Properties Real Estate Investment Trust from 2013 to 2018.
Prior to that, she was the Senior Director of Investor Relations at Nordion (Canada), Inc. and the Vice President of Investor Relations at Loblaw Cos.
Ltd.
from 2012 to 2013.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2024 | 6 753 ( 0,00% ) | 86 709 $ | 30.04.2024 |
Aktive Positionen von Kim Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| RIOCAN REAL ESTATE INVESTMENT TRUST | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Kim Lee
| Unternehmen | Position | Ende |
|---|---|---|
| MAPLE LEAF FOODS INC. | Investor Relations Kontakt | 01.01.2020 |
| CHOICE PROPERTIES REAL ESTATE INVESTMENT TRUST | Investor Relations Kontakt | 01.08.2018 |
| LOBLAW COMPANIES LIMITED | Investor Relations Kontakt | 01.03.2013 |
| NORDION INC | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| LOBLAW COMPANIES LIMITED | Retail Trade |
| CHOICE PROPERTIES REAL ESTATE INVESTMENT TRUST | Finance |
| MAPLE LEAF FOODS INC. | Distribution Services |
| RIOCAN REAL ESTATE INVESTMENT TRUST | Finance |
| Private Unternehmen | 1 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
